DK0590272T3 - 17beta-aryl og 17beta-heterocyclyl-5beta,14beta-androstanderivater med en virkning på det cardiovaskulære system, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende disse - Google Patents
17beta-aryl og 17beta-heterocyclyl-5beta,14beta-androstanderivater med en virkning på det cardiovaskulære system, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende disseInfo
- Publication number
- DK0590272T3 DK0590272T3 DK93112500.9T DK93112500T DK0590272T3 DK 0590272 T3 DK0590272 T3 DK 0590272T3 DK 93112500 T DK93112500 T DK 93112500T DK 0590272 T3 DK0590272 T3 DK 0590272T3
- Authority
- DK
- Denmark
- Prior art keywords
- 17beta
- heterocyclyl
- aryl
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 210000000748 cardiovascular system Anatomy 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4232638A DE4232638C2 (de) | 1992-09-29 | 1992-09-29 | 17-Phenyl-5beta-14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0590272T3 true DK0590272T3 (da) | 1997-04-14 |
Family
ID=6469142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93112500.9T DK0590272T3 (da) | 1992-09-29 | 1993-08-04 | 17beta-aryl og 17beta-heterocyclyl-5beta,14beta-androstanderivater med en virkning på det cardiovaskulære system, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende disse |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5567694A (de) |
| EP (1) | EP0590272B1 (de) |
| JP (1) | JPH06192286A (de) |
| KR (1) | KR940007055A (de) |
| AT (1) | ATE147077T1 (de) |
| CA (1) | CA2106917A1 (de) |
| DE (2) | DE4232638C2 (de) |
| DK (1) | DK0590272T3 (de) |
| ES (1) | ES2095531T3 (de) |
| GR (1) | GR3022376T3 (de) |
| HK (1) | HK1005878A1 (de) |
| ZA (1) | ZA937085B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5510340A (en) * | 1992-06-12 | 1996-04-23 | Sri International | Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| DE4232681C2 (de) * | 1992-09-29 | 1994-11-24 | Sigma Tau Ind Farmaceuti | 17-Phenyl- und 17-Furyl-14beta,5alpha-androstan- und androsten- Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung |
| EP1615944A4 (de) | 2003-04-01 | 2010-08-11 | Harbor Biosciences Inc | Antiandrogene mit marginaler agonistenwirkung und anwendungsverfahren |
| WO2007031833A2 (en) * | 2005-09-15 | 2007-03-22 | Council Of Scientific And Industrial Research | Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| CA2688079C (en) * | 2007-06-07 | 2016-05-03 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis |
| KR101656797B1 (ko) | 2009-03-23 | 2016-09-12 | 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. | 단백뇨, 사구체경화증 및 신부전의 치료에 유용한 5-β, 14-β-안드로스탄 유도체 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2614046C2 (de) * | 1976-04-01 | 1984-08-02 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue 17α-Hydroxy-Cardenolid-Glykoside, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| FR2407940A1 (fr) * | 1977-11-08 | 1979-06-01 | Roussel Uclaf | Nouveaux derives steroides 17 a-aryle, ou 17 a-heteroaryle, leur procede de preparation et leur application comme medicament |
| DE3223735A1 (de) * | 1982-06-25 | 1983-12-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue derivate von 17(alpha)-hydroxy-digitoxigenin-digitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneitmittel |
| JPH0368596A (ja) * | 1989-08-09 | 1991-03-25 | Snow Brand Milk Prod Co Ltd | １４α‐ヒドロキシ‐４‐アンドロステン‐３，６，１７‐トリオンの製造方法 |
-
1992
- 1992-09-29 DE DE4232638A patent/DE4232638C2/de not_active Expired - Fee Related
-
1993
- 1993-08-04 DK DK93112500.9T patent/DK0590272T3/da active
- 1993-08-04 AT AT93112500T patent/ATE147077T1/de active
- 1993-08-04 ES ES93112500T patent/ES2095531T3/es not_active Expired - Lifetime
- 1993-08-04 EP EP93112500A patent/EP0590272B1/de not_active Expired - Lifetime
- 1993-08-04 DE DE69307071T patent/DE69307071T2/de not_active Expired - Fee Related
- 1993-09-24 CA CA002106917A patent/CA2106917A1/en not_active Abandoned
- 1993-09-24 ZA ZA937085A patent/ZA937085B/xx unknown
- 1993-09-27 KR KR1019930019824A patent/KR940007055A/ko not_active Application Discontinuation
- 1993-09-29 JP JP5243359A patent/JPH06192286A/ja active Pending
- 1993-09-29 US US08/128,114 patent/US5567694A/en not_active Expired - Fee Related
-
1997
- 1997-01-23 GR GR970400113T patent/GR3022376T3/el unknown
-
1998
- 1998-06-05 HK HK98104947A patent/HK1005878A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69307071D1 (de) | 1997-02-13 |
| DE4232638A1 (de) | 1994-03-31 |
| EP0590272B1 (de) | 1997-01-02 |
| ZA937085B (en) | 1994-08-11 |
| GR3022376T3 (en) | 1997-04-30 |
| EP0590272A3 (en) | 1994-07-06 |
| CA2106917A1 (en) | 1994-03-30 |
| ES2095531T3 (es) | 1997-02-16 |
| HK1005878A1 (en) | 1999-01-29 |
| DE69307071T2 (de) | 1997-05-22 |
| KR940007055A (ko) | 1994-04-26 |
| JPH06192286A (ja) | 1994-07-12 |
| US5567694A (en) | 1996-10-22 |
| DE4232638C2 (de) | 1994-11-17 |
| EP0590272A2 (de) | 1994-04-06 |
| ATE147077T1 (de) | 1997-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2724292A (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid | |
| DK0590271T3 (da) | 17beta-aryl- og 17beta-heterocyclyl-5alfa, 14beta-androstan-, androsten- og -androstadienderivater med aktivitet på det kardiovaskulære system, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse | |
| DK0825197T3 (da) | Nye 6-hydroxy- og 6-oxo-androstanderivater, der er aktive i forhold til det cardiovaskulære system, og farmaceutiske præpar | |
| DE69231422D1 (de) | Pyridoncarbonsäurederivate | |
| DK0590272T3 (da) | 17beta-aryl og 17beta-heterocyclyl-5beta,14beta-androstanderivater med en virkning på det cardiovaskulære system, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende disse | |
| DK0583578T3 (da) | 17-(3-furyl)- og 17-(4-pyridazinyl)-5beta,14beta-androstanderivater med aktivitet på det cardiovaskulære system, fremgangsmåder til deres fremstilling og farmaceutiske præparater indeholdende disse | |
| NO900636L (no) | Fremgangsmaate for fremstilling av indolderivater. | |
| DK0688786T3 (da) | Hydrazino- og hydroxyamino-14beta-hydroxyandrostanderivater med aktivitet på det cardiovaskulære system, fremgangsmåder til deres fremstilling og farmaceutiske præparater indeholdende disse. | |
| GR3029466T3 (en) | 1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them | |
| EP0202084A3 (de) | Fluoralkanderivate | |
| DK0590489T3 (da) | Cyclopentanperhydrophenanthren-17beta-(hydroxy eller alkoxy)-17alfa-(aryl eller heterocyclyl)-3beta-derivater med aktivitet på det kardiovaskulære system, fremgangsmåder til fremstilling af disse og farmaceutiske præparater indeholdende disse | |
| DK0576913T3 (da) | Digitoxigenin og dihydrodigitoxigenin 3 beta-derivater samt farmaceutiske præparater indeholdende sådanne til behandling af hypertension | |
| HK1009334A1 (en) | New 17(3-imino-2-alkyl-propenyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same | |
| DE69701605D1 (de) | Im kardiovaskulären System aktive seco-D-Steroide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| GR3031908T3 (en) | Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same | |
| AU7613794A (en) | Glycosyl amides of 2-aminoacylamino-2-deoxy sugars |